Literature DB >> 34161226

Mental health and well-being during the COVID-19 pandemic: stress vulnerability, resilience and mood disturbances in fibromyalgia and rheumatoid arthritis.

Cristina Iannuccelli1, Bruno Lucchino2, Chiara Gioia1, Giulio Dolcini1, Martina Favretti1, Daniele Franculli1, Manuela Di Franco1.   

Abstract

OBJECTIVES: The COVID-19 pandemic severely increased the stress levels in the population. The aim of present study was to investigate the impact of the lockdown measures on emotional well-being and disease activity in patients with fibromyalgia (FM) and rheumatoid arthritis (RA) through a telemedicine approach.
METHODS: An on-line survey, including demographic characteristics, disease-activity and psychometric scales (Stress-related Vulnerability Scale, Resiliency scale), Zung Anxiety and Depression Self-assessment Scale), was anonymously administered to FM, RA and healthy controls (HC). Disease activities were compared to the pre-lockdown cohort referring to our centre.
RESULTS: Levels of anxiety and depression worthy of psychiatric attention were documented in 36.7% of FM, 14.6% of RA, 12.5% of HC and in 50% of FM, 17.1% of RA, 15% of HC, respectively. HC featured the highest stress scores, followed FM and then RA. RA showed higher resiliency than FM. Both anxiety and depression scores were significantly higher in FM than RA and HC. Disease severity was higher in RA patients and lower in FM patients when compared to the respective historical cohorts.
CONCLUSIONS: Lockdown significantly affected emotional well-being and disease activity of patients suffering from rheumatic diseases. While HC showed a higher vulnerability to stress, RA patients showed a greater resilience compared to both HC and to FM patients, especially. Emotional disturbances are greater in patients with RDs and in particular with FM. The use of a telemedicine approach to screen for severe symptoms represents a useful addition to the overall management of rheumatic patients.

Entities:  

Mesh:

Year:  2021        PMID: 34161226     DOI: 10.55563/clinexprheumatol/4nb0ku

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  5 in total

Review 1.  The relationship between COVID-19 and fibromyalgia syndrome: prevalence, pandemic effects, symptom mechanisms, and COVID-19 vaccines.

Authors:  Burhan Fatih Kocyigit; Ahmet Akyol
Journal:  Clin Rheumatol       Date:  2022-07-08       Impact factor: 3.650

2.  The impact of COVID-19 pandemic on mental and physical wellbeing in women with fibromyalgia: a longitudinal mixed-methods study.

Authors:  Asimina Lazaridou; Myrella Paschali; Eric S Vilsmark; Timothy Wilkins; Vitaly Napadow; Robert Edwards
Journal:  BMC Womens Health       Date:  2022-06-30       Impact factor: 2.742

Review 3.  The positive side of the coin: Sars-Cov-2 pandemic has taught us how much Telemedicine is useful as standard of care procedure in real life.

Authors:  Khadija El Aoufy; Maria Ramona Melis; Silvia Bellando Randone; Jelena Blagojevic; Francesca Bartoli; Ginevra Fiori; Francesca Nacci; Maria Letizia Conforti; Laura Cometi; Cosimo Bruni; Martina Orlandi; Alberto Moggi-Pignone; Laura Rasero; Serena Guiducci; Marco Matucci-Cerinic
Journal:  Clin Rheumatol       Date:  2021-11-05       Impact factor: 2.980

4.  A better but persistently low health status in women with fibromyalgia during the COVID-19 pandemic: a repeated cross-sectional data analysis.

Authors:  Tim Y Koppert; Henriët van Middendorp; Rinie Geenen
Journal:  Rheumatol Int       Date:  2022-04-12       Impact factor: 3.580

5.  Psychological Stress Reported at the Start of the COVID-19 Pandemic and Subsequent Stress and Successful Coping in Patients With Rheumatic Diseases: A Longitudinal Analysis.

Authors:  Roland Duculan; Deanna Jannat-Khah; Xin A Wang; Carol A Mancuso
Journal:  J Clin Rheumatol       Date:  2022-04-22       Impact factor: 3.902

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.